fda warning letters compounded semaglutide 2025 september alerts health care providers, compounders and patients of dosing errors associated with injectable products The FDA sent a warning

This formulation is less common than the B12 combinations but appeals to patients interested in niacinamide-enhanced GLP-1 compounds

Your gut can handle a steady trickle

Caffeine Heres some bad news for people, especially women, who drink coffee, tea and/or caffeinated sodas

It is also important to note that these medications were well tolerated by these groups of patients without major adverse effects described in the evaluated trials. Specifically, GLP-1 RAs produced a mean weight loss of 5.03 kg (corresponding to 4.15% body weight reduction) compared to controls, along with significant improvements in BMI (1.59 kg/m), waist circumference (3.40 cm), and fasting glucose (0.29 mmol/L)

The findings were reported in the paper, Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation, published in Cell Metabolism

Is reconstitution the same as dosing